Cancer Clinical Trials
This is a current listing of active clinical trials at the Aspirus Regional Cancer Center. From this list you can select a specific cancer that you are interested in (for example, breast or colon cancer) and then review the clinical trials that are active at the Aspirus Regional Cancer Center for that specific disease.
Breast Cancer - Ductal Carcinoma In Situ
Trial Name: Name of Trial: A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy.
Protocol ID: NSABP B-43
Enrollment: Enrollment: · About 2000 women will take part in this study.
Taking part in this study may or may not make your health better. While doctors hope that adding trastuzumab to radiation therapy will be more useful in the treatment of HER2-positive DCIS compared to radiation therapy without trastuzumab, there is no proof of this yet. We do know that the information from this study will help doctors learn more about trastuzuamb given with radiation therapy as a treatment for HER2-positive DCIS. This information could help future breast cancer patients.
These clinical trial overviews are intended to provide a brief overview of the clinical trial. To help determine whether the trial is appropriate for you, the major eligibility criteria are listed above. To obtain more information on the eligibility and the treatment plan, please contact our Aspirus Regional Cancer Center Oncology Clinical Research Coordinator, Beth Knetter at 715-847-2353 or 1-800-283-2881, ext.72353, or Langlade Cancer Center Research Nurse Debra Witman @ 715-623-9587.
Created: Jul 31, 2009
Updated: May 21, 2014